Funding sources NHMRC application number 1013349; Cancer and Palliative Care Research and Evaluation Unit WAPCN Small Grants 2010/11; and Cancer Council of WA Research Grant (to M.Z and S.M.). Grant support MHF: National Institutes of Health (U.S.A.) grant numbers 5R01CA113796, 1R01CA158467, 1R01CA138231 and 2P50CA093683 (to M.H.F).
CLINICAL AND LABORATORY INVESTIGATIONS
Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression
Version of Record online: 15 NOV 2012
© 2012 The Authors. BJD © 2012 British Association of Dermatologists
British Journal of Dermatology
Volume 168, Issue 1, pages 85–92, January 2013
How to Cite
Reid, A.L., Millward, M., Pearce, R., Lee, M., Frank, M.H., Ireland, A., Monshizadeh, L., Rai, T., Heenan, P., Medic, S., Kumarasinghe, P. and Ziman, M. (2013), Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. British Journal of Dermatology, 168: 85–92. doi: 10.1111/bjd.12057
Conflicts of interest None declared.
- Issue online: 21 DEC 2012
- Version of Record online: 15 NOV 2012
- Accepted manuscript online: 26 SEP 2012 12:15PM EST
- Accepted for publication 14 September 2012
Table S1. Quantitative real-time polymerase chain reaction primer sequences (sense and antisense) (Geneworks)
Table S2. Endpoint polymerase chain reaction primer sequences (sense and antisense) (Geneworks)
Table S3. Generalized linear model analysis examining the effect of time on individual marker expression in serial blood collections
|BJD_12057_sm_TableS1-S2.doc||41K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.